Skip to main navigation Skip to search Skip to main content

Investigators from Stanford University Zero in on Heart Disease (Sglt2 Inhibitor Ameliorates Endothelial Dysfunction Associated With the Common Aldh2 Alcohol Flushing Variant)

Press/Media

PeriodMar 24 2023

Media coverage

1

Media coverage

  • TitleInvestigators from Stanford University Zero in on Heart Disease (Sglt2 Inhibitor Ameliorates Endothelial Dysfunction Associated With the Common Aldh2 Alcohol Flushing Variant)
    Media name/outletHeart Disease Daily
    Country/TerritoryUnited States
    Date03/24/23
    PersonsYu Sunny Liu